NanoViricides Inc. (NNVC) Dividend History

NanoViricides Inc. (NNVC) is a biotechnology company focused on developing nanotechnology-based antiviral drugs. The company's approach involves designing targeted nanomedicines to neutralize viruses and treat viral infections, including emerging and persistent viral threats. NanoViricides aims to create broad-spectrum antivirals that can address a wide range of viral diseases.

Dividend History

NanoViricides Inc. currently does not pay dividends

Company News

  • Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket

    Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. Better Therapeutics, Inc. (NASDAQ: BTTX) shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes. Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 42.2% to $0.1450 in pre-market trading after declining around 14% on Monday. Trinity Place Holdings Inc. (NYSE: TPHS) gained 24.1% to $0.6790 in pre-market trading after declining around 15% on Monday. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares rose 20.8% to $0.54 in pre-market trading. NanoViricides, Inc. (NYSE: NNVC) rose 19.9% to $1.69 in pre-market trading. NanoViricides reported effectiveness of antiviral clinical drug candidate NV-387 in an animal model of lethal lung infection with respiratory syncytial virus. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares climbed 18.2% to $5.86 in pre-market trading. Acumen Pharmaceuticals recently announced it ...

    Benzinga
    Featured Companies: ABOS CNEY DERM DSS GDTC IOVA REE RVYL UGRO VRDN
  • NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City

    SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The Inaugural EF Hutton Global Conference, which will be held on May 10-11, 2023, at the Plaza Hotel in the heart of New York City. NanoViricides is presenting on May 10th.

    GlobeNewswire Inc.
  • 10 Top Monkeypox Stocks To Watch Right Now

    10 monkeypox stocks and monkeypox penny stocks to watch The post 10 Top Monkeypox Stocks To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AEMD APDN EJH GOVX SIGA TNXP
  • Company News for Sep 28, 2021

    Companies in the news are: BYND, RCAT, ITCI, NNVC

    Zacks Investment Research
    Featured Companies: BYND RCAT
Page data last updated 08/19/2025 16:54:20 UTC